Immunotherapy group:None

4 trials

Sponsors

Jiangsu Cancer Hospital(The affliated Cancer Hospital of Nanjing Medical University), Shanghai General Hospital, West China Hospital, Sichuan University, The FIrst Affiliated Hospital, College of Medicine, Zhejiang University

Conditions

Acute-on-chronic liver failure with all etiologiesBladder cancerGastric canceresophageal tumor

Unknown Phase

Effect of different neoadjuvant treatment regimens on intraoperative hypotension and postoperative related complications in patients with esophageal cancer: a real-world study

RecruitingChiCTR2400089724

Jiangsu Cancer Hospital(The affliated Cancer Hospital of Nanjing Medical University)esophageal tumor

Start: 2024-03-01Updated: 2024-09-16

Construction and validation of a bladder cancer efficacy prediction system based on multimodal and multi-omics features

Active, not recruitingChiCTR2500097266

Shanghai General HospitalBladder cancer

Start: 2025-02-22Updated: 2025-02-24

Non-surgical management after neoadjuvant immunotherapy for locally advanced dMMR/MSI-H gastric cancer: WWWGC Phase II study

Active, not recruitingChiCTR2600120174

West China Hospital, Sichuan UniversityGastric cancer

Start: 2026-03-13Updated: 2026-03-16

Study on immunotherapy in patients with acute-on-chronic liver failure

RecruitingChiCTR2600127123

The FIrst Affiliated Hospital, College of Medicine, Zhejiang UniversityAcute-on-chronic liver failure with all etiologies

Start: 2025-10-28Updated: 2026-06-29